Incyte News

Wells Fargo Adjusts Incyte's Price Target to $70 From $68, Keeps Equalweight Rating

MT NewswiresDec 19 09:39 ET

Analysts Offer Insights on Healthcare Companies: Century Therapeutics (IPSC), Incyte (INCY) and Bicycle Therapeutics (BCYC)

TipRanksDec 18 00:41 ET

Incyte Analyst Ratings

BenzingaDec 17 14:43 ET

UBS Initiates Incyte(INCY.US) With Hold Rating, Announces Target Price $77

Moomoo NewsDec 17 10:32 ET

JMP Securities Maintains Incyte(INCY.US) With Hold Rating

Moomoo NewsDec 17 00:32 ET

Incyte's Mixed Clinical Results and Financial Challenges Lead to Hold Rating

TipRanksDec 17 00:31 ET

Oppenheimer Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $82

Moomoo NewsDec 13 16:31 ET

Stifel Maintains Incyte(INCY.US) With Hold Rating, Maintains Target Price $75

Moomoo NewsDec 13 08:32 ET

TD Cowen Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $86

Moomoo NewsDec 13 07:31 ET

BMO Capital Maintains Incyte(INCY.US) With Sell Rating, Maintains Target Price $52

Moomoo NewsDec 13 07:31 ET

TD Cowen Reaffirms Their Buy Rating on Incyte (INCY)

TipRanksDec 13 07:28 ET

Stifel Maintains Incyte(INCY.US) With Hold Rating, Maintains Target Price $75

Moomoo NewsDec 10 08:31 ET

Stifel Nicolaus Sticks to Their Hold Rating for Incyte (INCY)

TipRanksDec 10 07:47 ET

Analysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS), Incyte (INCY) and Prenetics Group (PRE)

TipRanksDec 5 11:04 ET

RBC Capital Sticks to Its Hold Rating for Incyte (INCY)

TipRanksNov 27 20:49 ET

TD Cowen Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $86

Moomoo NewsNov 25 08:32 ET

TD Cowen Remains a Buy on Incyte (INCY)

TipRanksNov 25 07:53 ET

TD Cowen Adjusts Price Target on Incyte to $86 From $80, Keeps Buy Rating

MT NewswiresNov 25 06:48 ET

Incyte Is Maintained at Sector Perform by RBC Capital

Dow JonesNov 19 10:52 ET

BofA Securities Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $86

Moomoo NewsNov 19 09:32 ET